Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | Patient-reported outcomes in HSCT

Hélène Schoemans • 14 Mar 2021
EBMT 2021
General

Patient-reported outcomes provide health information directly from the patient and may aid in hematopoietic stem-cell transplantation (HSCT) prognostication. In this video, Hélène Schoemans, MD, University of Leuven, Leuven, Belgium, discusses the use of patient-reported outcomes in HSCT. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Hélène Schoemans, MD, has participated in advisory boards for Incyte, Janssen, and Novartis; has received speaker’s fees from Novartis, Incyte, Jazz Pharmaceuticals, the Belgian Hematological Society (BHS) and Takeda; has received travel grants from AbbVie, Celgene, CIBMTR, EBMT, Gilead and Incyte, has received research funding from Novartis and the BHS; and has volunteered for the BHS, the CIBMTR, EBMT, and EUPATI.

More from Hélène Schoemans

1:37
The importance of patient engagement
Hélène Schoemans • 14 Mar 2021
1:01
HSCT for the trainee
Hélène Schoemans • 14 Mar 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals